Syncona Limited

Syncona Ord's mission is to invest in and build global leaders in life science, with a focus on delivering transformational treatments to patients. Their core values emphasize long-term commitment to their companies, striving for excellence, and integrity, ensuring their activities consistently benefit all stakeholders.

Syncona Ltd, known as Syncona Ord in the context of its stock listing, was founded in 2012 as a subsidiary of the Wellcome Trust, a biomedical research charity based in London, UK.

As of my last available information, the leadership at Syncona Ltd, which is sometimes referred to as Syncona Ord based on its ordinary shares, could change over time, therefore it is best to check the company's official website or the most recent financial reports for the current leadership team. Traditionally, the leadership would include positions such as the Chief Executive Officer (CEO) and the Board of Directors, among others.

Syncona Ord is based in the United Kingdom and is a British investment company focused on life sciences and healthcare.

Syncona Ord, known under the ticker symbol SYNC, is primarily listed on the London Stock Exchange (LSE).